Clinical Pathway for Evaluation/Treatment of Children
with Suspected Atopic Dermatitis

Topical Steroids Treatment Recommendations by Flare Severity, Skin Location, Patient Age
Severity Location

Age < 3 yrs

Ointment covered by most insurance payers

Age ≥ 3 yrs

Ointment covered by most insurance payers
Potency
Class
Mild Face/Genitals 2.5% Hydrocortisone base 2.5% Hydrocortisone base Lowest
Class VII
Mild Body 2.5% Hydrocortisone base 0.025% Triamcinolone acetonide Lower-Medium
Class VI
Moderate Face/Genitals 0.025% Triamcinolone acetonide 0.025% Triamcinolone acetonide Lower-Medium
Class VI
Moderate Body 0.025% Triamcinolone acetonide 0.1% Triamcinolone acetonide Medium
Class V
Severe Face/Genitals 0.025% Triamcinolone acetonide 0.025% Triamcinolone acetonide Lower-Medium
Class VI
Severe Body 0.1% Triamcinolone acetonide 0.05% Fluocinonide High
Class II
  • FLOC, RN Team Assessment
  • Always use Steroid Medication in ointment formulation, Recommended ointment covered by most insurance payers If patient already using applicable medication, refer to Steroid Potency Table
  • CHOP Formulary  
Posted: October 2018
Reviewed: October 2020
Authors: L. Castelo-Soccio MD; K. Woo Castelo CRNP; M. Jen MD; C. Tucker MD; K. Gupta MD; C. Yun MD; J Hart MD
E. Delgado MD; L. Wilson RN; B. Johnson RN; A. Verma MD; M. Perman MD; J. Treat MD